Cargando…

Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD

Inhaled corticosteroids (ICS) use is associated with an increased risk of Pseudomonas aeruginosa (PA) infection in patients with COPD. We aimed to evaluate the effects of ICS on alveolar macrophages in response to PA in COPD patients with and without baseline ICS treatment (COPD and COPD + ICS, resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerón-Pisa, Noemi, Shafiek, Hanaa, Martín-Medina, Aina, Verdú, Javier, Jordana-Lluch, Elena, Escobar-Salom, Maria, Barceló, Isabel M., López-Causapé, Carla, Oliver, Antonio, Juan, Carlos, Iglesias, Amanda, Cosío, Borja G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332726/ https://www.ncbi.nlm.nih.gov/pubmed/35897707 http://dx.doi.org/10.3390/ijms23158127

Ejemplares similares

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
por: Martín-Medina, Aina, et al.
Publicado: (2022)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD
por: Cosío, Borja G., et al.
Publicado: (2015)

The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research
por: Jordana-Lluch, Elena, et al.
Publicado: (2023)

Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa
por: Barceló, Isabel M., et al.
Publicado: (2022)

Characterization of COPD Admissions During the First COVID-19 Outbreak
por: Cosio, Borja G, et al.
Publicado: (2021)

Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential
por: Escobar-Salom, María, et al.
Publicado: (2023)

Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence
por: Barceló, Isabel M., et al.
Publicado: (2022)

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations
por: Shafiek, Hanaa, et al.
Publicado: (2015)

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
por: Fernández-Billón, María, et al.
Publicado: (2023)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram‐negatives
por: Escobar‐Salom, María, et al.
Publicado: (2022)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2017)

Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections
por: Torrens, Gabriel, et al.
Publicado: (2019)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy
por: Riera-Martínez, Lluc, et al.
Publicado: (2023)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins
por: Torrens, Gabriel, et al.
Publicado: (2019)

Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins
por: Torrens, Gabriel, et al.
Publicado: (2020)

Inhaled Corticosteroids and Bone Health
por: Chee, Carolyn, et al.
Publicado: (2014)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Before and beyond Inhaled Corticosteroids
por: Vazquez Guillamet, Rodrigo
Publicado: (2020)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
por: Liu, Shih-Feng, et al.
Publicado: (2016)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
por: Ozcakir, Suheda, et al.
Publicado: (2020)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

The Effects of Inhaled Corticosteroids on Growth in Children
por: Philip, Jim
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_du6d5ahli470us7o1dil2v44nd